Immunotherapy
HealthNew anticancer drugs could significantly improve immunotherapy
EZH2 inhibitors significantly enhance lymphoma immunotherapies, improving CAR-T and antibody therapy outcomes in preclinical studies.
Joshua ShavitEZH2 inhibitors significantly enhance lymphoma immunotherapies, improving CAR-T and antibody therapy outcomes in preclinical studies.
Joshua Shavit